Myeloproliferative Neoplasm Gene Panels (Not Accredited)


We are not currently accepting registrations for this pre-pilot programme.   We will however be issuing a survey imminently inviting participants to register an interest for the next trial issue which we hope to send later in 2018.  In this study, a cell line or patient sample will be issued alongside a clinical scenario. Participants will be expected to test the sample  with their in-house strategy for testing MPNs. The programme primarily focusses on JAK2 (V617F and exon  12), CALR  and MPL mutations (Tefferi & Pardanani, 2014). However results from broader panels are accepted.      

Print Print | Sitemap

Follow Us Online!
Facebook Twitter LinkedIn Youtube


Last updated 21st November 2017 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.

This website uses cookies. For more information, please click here.

The UK NEQAS Organisation is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).